PDCD1 and neoplasm: These results seemingly conflict with well-characterized mechanisms of primary20 and secondary resistance19 to anti-PD-1, as well as the predictive role of tumor IFNy-associated gene expression signatures in response to checkpoint blockade31, although these studies focused on IFNy signaling in tumor tissue as opposed to serum concentrations of the cytokine.